LAPAROSCOPIC NEPHRECTOMY IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

Aim. To assess the possibilities of the use of laparoscopic transabdominal nephrectomy (LNE) for surgical treatment and preparation of the patients with autosomal dominant polycystic kidney disease (ADPKD) for kidney transplantation. Materials and тethods. In the course of the study 28 patients who underwent nephrectomy of a polycystic-modifi ed kidney were analyzed and divided into two groups. The fi rst group (15 patients) underwent open surgical intervention with the use of midline laparotomy and lumbotomy (16 operations), of which: bilateral nephrectomy – 11 (68.7%), monolateral nephrectomy – 5 (31.3%). In the second group (13 patients), laparoscopic transabdominal monolateral nephrectomy (17 operations) was done. Surgical interventions were performed for emergency indications and to prepare for kidney transplantation. Results. The average duration of laparoscopic and open surgical interventions was not signifi cantly different and amounted in the fi rst and second group to 146 ± 14 and 124 ± 11 minutes (p > 0.05), respectively. The frequency of postoperative complications after open surgical interventions made up 43.75%, the mortality rate was 6.25% (1 case). In patients operated on laparoscopically postoperative complications occurred in 11.8% of cases. Patients after laparoscopic procedures were activated in 2–3 days (2.63 ± 0.23), after open operations on 4–5 (4.13 ± 0.39, p < 0.05). The average length of postoperative hospital stay was in the fi rst group – 13–14 (13.7 ± 1.3), in the second group – 7–8 (7.7 ± 0.5, p < 0.05). Conclusion. Atraumatic laparoscopic technology leads to a more favorable course of the postoperative period after nephrectomy. It can reduce the duration of inpatient treatment and help activate patients at an earlier date. The method of LNE can signifi cantly reduce the frequency of postoperative complications and expand the possibilities of using nephrectomy in the treatment and management of patients with autosomal dominant poly￾cystic kidney disease waiting for renal transplantation.

laparoscopic nephrectomy, autosomal dominant polycystic kidney disease, kidney transplantation

1. Akoh JA. Current management of autosomal dominant polycystic kidney disease. World J. Nephrol. 2015 Sep 6; 4 (4): 468–479. doi: 10.5527/wjn.v4.i4.468.

2. Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S et al. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2015 Jul; 88 (1): 17–27. doi: 10.1038/ki.2015.59.

3. Ермоленко ВМ, Батэрдэнэ С. Аутосомно-доминантная поликистозная болезнь почек: новые патогенетические и терапевтические аспекты. Нефрология и диализ. 2008; 10 (2): 111–122. Ermolenko VM, Baterdene S. Autosomal dominant polycystic kidney disease (ADPKD): new pathogenetic and therapeutic approach. Nefrologiya i dializ. 2008; 10 (2): 111–122. [In Russ].

4. Казимиров ВГ, Бутрин СВ, Сапожников АД. Трансплантация почки у больных с аутосомно-доминан- тным поликистозом почек. Волгоград: Издатель, 2003. 112 с. Ka zi mi rov VG, Butrin SV, Sapozhnikov AD. Transplanta tsi ya pochki u bol’nykh s autosomno-dominantnym po li kis to zom pochek. – Volgograd: Izdatel’, 2003. 112 s. [In Russ].

5. Кутырина ИМ. Поликистоз почек. Нефрология. Национальное руководство. Ред. Н.А. Мухин. М.: ГЭОТАР-Медиа 2009: 508–512. Kutyrina I.M. Polikistoz pochek. Nefrologiya. Natsional’noe rukovodstvo. Red. N.A. Mukhin. M.: GEOTAR-Media 2009: 508–512. [In Russ].

6. Chebib FT, Prieto M, Jung Y, Irazabal MV, Kremers WK, Dean PG et al. Native Nephrectomy in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease. Transplant Direct. 2015 Nov 1; 1 (10): e43.

7. Cristea O, Yanko D, Felbel S, House A, Sener A, Luke PP. Maximal kidney length predicts need for native nephrectomy in ADPKD patients undergoing renal transplantation. Can. Urol. Assoc. J. 2014 Jul; 8 (7–8): 278–282. doi: 10.5489/cuaj.2128.

8. Cohen D, Timsit MO, Chrétien Y, Thiounn N, Vassiliu V, Mamzer MF et al. Place of nephrectomy in patients with autosomal dominant polycystic kidney disease waiting for renal transplantation. Prog. Urol. 2008 Nov; 18 (10): 642–649. doi: 10.1016/j.purol.2008.06.004.

9. Patel MS, Kandula P, Wojciechowski D, Markmann JF, Vagefi PA. Trends in the management and outcomes of kidney transplantation for autosomal dominant polycystic kidney disease. J. Transplant. 2014 (1): 675697. doi: 10.1155/2014/675697.

10. Shumate AM, Bahler CD, Goggins WC, Sharfuddin AA, Sundaram CP. Native Nephrectomy with Renal Transplantation is Associated with a Decrease in Hypertension Medication Requirements for Autosomal Dominant Polycystic Kidney Disease. J. Urol. 2016 Jan; 195 (1): 141–146. doi: 10.1016/j.juro.2015.07.114.

11. Binsaleh S, Luke PP, Nguan C, Kapoor A. Comparison of laparoscopic and open nephrectomy for adult polycystic kidney disease: operative challenges and technique. Can. J. Urol. 2006 Dec; 13 (6): 3340–3345.

12. Bansal RK, Kapoor А. Laparoscopic nephrectomy for massive polycystic kidney disease: Updated technique and outcomes. Can. Urol. Assoc J. 2014 Sep-Oct; 8 (9– 10): 341–345. doi: 10.5489/cuaj.2097.

13. Eng M, Jones CM, Cannon RM, Marvin MR. Hand-assisted laparoscopic nephrectomy for polycystic kidney disease. JSLS. 2013 Apr-Jun; 17 (2): 279–284. doi: 10.4 293/108680813X13654754535719.

14. Verhoest G, Delreux A, Mathieu R, Patard J, Vigneau C, Rioux-Leclercq N et al. Transperitoneal Laparoscopic Nephrectomy for Autosomal Dominant Polycystic Kidney Disease. JSLS. 2012 Jul-Sep; 16 (3): 437–442. doi: 10.4293/108680812X13462882736

15. Трушкин РН, Лубенников АЕ, Сысоев АМ, Соколов АА. Нефрэктомия у больных с терминальной стадией хронической почечной недостаточности и активным течением пиелонефрита. Экспериментальная и клиническая урология. 2015; 4: 104–109. Trushkin RN, Lubennikov AE, Sysoev AM, Sokolov AA. Nefrektomiya u bol’nykh s terminal’noy stadiey khronicheskoy pochechnoy nedostatochnosti i aktivnym techeniem pielonefrita. Eksperimental’naya i klinicheskaya urologiya. 2015; 4: 104–109.